https://the483.com/west-coast-chatbot-trio-ca-or-wa/ The 483 en 2026-04-21T11:30:00.000Z West Coast Chatbot Laws: California Live, Oregon and Washington Queue Up for 2027 https://the483.com/texas-traiga-110-days-enforcement-posture/ The 483 en 2026-04-21T11:00:00.000Z Texas TRAIGA at 110 Days — What the 60-Day Cure Period Actually Buys You https://the483.com/mobley-workday-hiredscore-ai-hiring-class/ The 483 en 2026-04-21T10:30:00.000Z Mobley v. Workday Expanded to HiredScore Users — The AI-Hiring Class Widens https://the483.com/ftc-rytr-order-set-aside-ai-comply-retreat/ The 483 en 2026-04-21T10:00:00.000Z FTC Set Aside Its Rytr AI Order — Operation AI Comply Is Selectively Retreating https://the483.com/colorado-ai-act-june-2026-10-weeks/ The 483 en 2026-04-21T09:30:00.000Z Colorado AI Act Goes Live in 10 Weeks — What High-Risk Deployers Owe June 30 https://the483.com/sec-nate-saniger-42m-ai-washing/ The 483 en 2026-04-21T09:00:00.000Z SEC Charged Nate Founder $42M for AI-Washing — What Founders Learn a Year Later https://the483.com/cbp-ieepa-tariff-refunds-walmart/ The 483 en 2026-04-21T03:10:50.000Z Opened: CBP's $127B Tariff Refund Portal; Walmart Owed $10.2B https://the483.com/zaglin-drops-new-trial-motion/ The 483 en 2026-04-21T02:47:40.960Z Zaglin Drops New Trial Motion, 8-Year FCPA Sentence Stands https://the483.com/trump-eo-psychedelic-compass-review/ The 483 en 2026-04-21T00:45:17.000Z Trump EO Cuts Psychedelic Reviews, Compass Jumps 25% https://the483.com/lilly-kelonia-7b-igps-platform/ The 483 en 2026-04-20T23:19:52.000Z Lilly Cuts $7B Deal for Kelonia and Its iGPS Platform https://the483.com/kelonia-lilly-venrock-45-fold/ The 483 en 2026-04-20T22:19:54.000Z Kelonia Sale Hands Venrock a 45-Fold Return on $20M https://the483.com/trump-fda-fast-track-psychedelic-treatments/ The 483 en 2026-04-20T21:33:33.312Z Trump Backs FDA Push to Fast-Track Psychedelic Treatments https://the483.com/astrazeneca-tozorakimab-third-phase3-win/ The 483 en 2026-04-20T17:27:18.000Z Wins Third Phase 3 in COPD: AstraZeneca's Tozorakimab Eyes $5B Peak https://the483.com/lilly-kelonia-vivo-car-t-deal/ The 483 en 2026-04-20T16:31:25.000Z Lilly Bets on Kelonia's In Vivo CAR-T https://the483.com/novo-etavopivat-scd-fda-filing/ The 483 en 2026-04-20T13:51:19.530Z Novo Targets FDA Filing for Etavopivat After 27% VOC Reduction